RIL
VIR icon

Rothschild Investment LLC’s Vir Biotechnology VIR Stock Holding History

Rothschild Investment LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68K Sell
263
-8
-3% -$76 ﹤0.01% 2630
2026
Q1 		$2.43K Buy
+271
New +$2.16K ﹤0.01% 2460
2025
Q2 		– Sell
-160
Closed -$1.04K – 3198
2025
Q1 		$1.04K Buy
160
+40
+33% +$356 ﹤0.01% 2320
2024
Q4 		$881 Buy
120
+40
+50% +$316 ﹤0.01% 2285
2024
Q3 		$599 Buy
80
+20
+33% +$174 ﹤0.01% 2418
2024
Q2 		$534 Buy
60
+50
+500% +$479 ﹤0.01% 1970
2024
Q1 		$101 Buy
+10
New +$102 ﹤0.01% 2209
2023
Q3 		– Sell
-24,850
Closed -$610K – 497
2023
Q2 		$610K Sell
24,850
-3,400
-12% -$85.4K 0.05% 276
2023
Q1 		$657K Sell
28,250
-300
-1% -$7.67K 0.06% 266
2022
Q4 		$723K Sell
28,550
-5,100
-15% -$125K 0.07% 245
2022
Q3 		$649K Sell
33,650
-1,500
-4% -$38.1K 0.06% 251
2022
Q2 		$895K Sell
35,150
-2,100
-6% -$49K 0.08% 225
2022
Q1 		$958K Sell
37,250
-1,300
-3% -$38.6K 0.08% 234
2021
Q4 		$1.61M Hold
38,550
– – 0.13% 161
2021
Q3 		$1.68M Sell
38,550
-2,000
-5% -$86.6K 0.14% 153
2021
Q2 		$1.92M Sell
40,550
-900
-2% -$40.9K 0.15% 141
2021
Q1 		$2.13M Buy
41,450
+18,550
+81% +$1,000K 0.18% 123
2020
Q4 		$613K Buy
22,900
+10,150
+80% +$330K 0.06% 257
2020
Q3 		$438K Buy
+12,750
New +$549K 0.05% 278

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rothschild Investment LLC's VIR Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Vir Biotechnology (VIR) stake by 3% in Q2 2026, selling an estimated $76 and leaving 263 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

Rothschild Investment LLC first reported a position in VIR in Q3 2020 and has held it in 19 quarters since. The position peaked at $2.13M in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Rothschild Investment LLC held 263 shares of Vir Biotechnology worth $2.68K as of Q2 2026.
  • Rothschild Investment LLC sold 8 Vir Biotechnology shares in Q2 2026, an estimated $76.
  • Vir Biotechnology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2630 holding.
  • Rothschild Investment LLC first reported a position in Vir Biotechnology in Q3 2020 and has held it in 19 quarters since.
  • Rothschild Investment LLC's Vir Biotechnology position peaked at $2.13M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.